| Literature DB >> 11509620 |
D Le Roy1, F Di Padova, Y Adachi, M P Glauser, T Calandra, D Heumann.
Abstract
LPS-binding protein (LBP) and CD14 potentiate cell activation by LPS, contributing to lethal endotoxemia. We analyzed the contribution of LBP/CD14 in models of bacterial infection. Mice pretreated with mAbs neutralizing CD14 or LBP showed a delay in TNF-alpha production and died of overwhelming infection within 24 h, after a challenge with 250 CFU of virulent Klebsiella pneumoniae. Blockade of TNF-alpha also increased lethality, whereas pretreatment with TNF-alpha protected mice, even in the presence of LBP and CD14 blockade. Anti-LBP or anti-CD14 mAbs did not improve or decrease lethality with a higher inoculum (10(5) K. pneumoniae) and did not affect outcome following injections of low or high inocula of Escherichia coli O111. These results point to the essential role of LBP/CD14 in innate immunity against virulent bacteria.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11509620 DOI: 10.4049/jimmunol.167.5.2759
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422